Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Macitentan or its derivativesPDL I DEC / 13
Magnesium glutamate hydrobromidePDL I DEC / 13
Magnesium sulfate for parenteral use II SEP / 98
Magnesium sulfate in injectable form for parenteral nutrition I JAN / 03
Manganese and its salts

In injectable form for parenteral nutrition.

I JAN / 03
Mannitol PDL

When sold and recommended for use as a diagnostic agent for the assessment of bronchial hyperresponsiveness.

I OCT / 19
Mannitol and its salts

Except when sold and recommended for use as a diagnostic agent for the assessment of bronchial hyperresponsiveness.

II OCT / 19
Maprotiline or its saltsPDL I DEC / 13
MaravirocPDL I DEC / 13
Marbofloxacin or its salts or derivativesPDL I DEC / 13
Maropitant or its saltsPDL I DEC / 13
Mazindol and its saltsTS I SEP / 98
Measles vaccine II DEC / 98
MebendazolePDL

For human use.

I DEC / 13
MebendazolePDL

For veterinary use - when sold to treat dogs only.

I DEC / 13
MebolazineC3 I JUN / 02
Mecamylamine or its saltsPDL I DEC / 13
Mechlorethamine or its saltsPDL I DEC / 13
Mecillinam or its salts or derivativesPDL

For veterinary use.

I DEC / 13
Meclizine and its salts.

when sold in concentrations of 25 mg or less per dosage unit

III MAY / 00
Meclizine or its saltsPDL

For human use - when sold in concentrations greater than 25 mg per dosage unit.

I DEC / 13
Meclofenamic acid or its saltsPDL I DEC / 13
Mecloqualone and any salt thereofC5 I JAN / 03
MedazepamTS I JUN / 02
Medetomidine or its saltsPDL I DEC / 13
Mefenamic acid or its saltsPDL I DEC / 13
MefenorexTS I JUN / 02
Mefloquine or its salts or derivativesPDL I DEC / 13
Megestrol or its saltsPDL I DEC / 13
Melanoma therapeutic vaccinePDL I DEC / 13
Melarsomine or its saltsPDL

For human use

I DEC / 13
Melarsomine or its saltsPDL

For veterinary use - when sold for the treatment of heartworm in dogs.

I DEC / 13
Meloxicam or its salts or derivativesPDL I DEC / 13
MelphalanPDL I DEC / 13
Memantine or its saltsPDL I DEC / 13
Meningococcus vaccine II MAR / 01
Menotropins (human)PDL I DEC / 13
Mepacrine or its saltsPDL I DEC / 13
Mepazine or its saltsPDL I DEC / 13
MephenoxalonePDL I DEC / 13
Mephentermine or its saltsPDL I DEC / 13
MephobarbitalC2 I JUN / 02
Mepivacaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Mepivacaine and its salts for ophthalmic or parenteral use II SEP / 98
MepolizumabPDL I AUG / 16
MeprobamateTS I SEP / 98
Mepyramine see pyrilamine U
MercaptopurinePDL I DEC / 13
MesaboloneC3 I JUN / 02
MesnaPDL I DEC / 13
Mesocarb and any salt thereofC4 I JAN / 03
Mesoridazine or its saltsPDL I DEC / 13
MesteroloneC3 I JUN / 02
MetaldehydePDL I DEC / 13
MetandienoneC3 I JUN / 02
Metaraminol bitartrate I SEP / 98
Metathoheptazine and its salts II SEP / 98
MetazocineN I JUN / 02
MetenoloneC3 I JUN / 02
Metformin or its salts or derivativesPDL I DEC / 13
MethabarbitalC2 I JUN / 02
Methacholine chloridePDL I DEC / 13
MethadoneN I JUN / 02
MethamphetamineC1 I JUN / 02
MethandriolC3 I JUN / 02
Methantheline and its salts II SEP / 98
MethaqualoneC1 I JUN / 02
Methazolamide or its saltsPDL I DEC / 13
Methdilazine and its salts II SEP / 98
Methenamine and its salts except for topical use II SEP / 98
Metheptazine and its salts II SEP / 98
Methicillin or its salts or derivativesPDL

For veterinary use.

I DEC / 13
MethimazolePDL I DEC / 13
MethisazonePDL I DEC / 13
Methocarbamol for parenteral use II SEP / 98
Methocarbamol. except for parenteral use III SEP / 98
Methoin (Mephenytoin) or its saltsPDL I DEC / 13
Methotrexate or its saltsPDL I DEC / 13
Methotrimeprazine or its saltsF1 I DEC / 13
Methoxamine or its saltsPDL I DEC / 13
MethoxsalenPDL I DEC / 13
Methoxy polyethylene glycol-epoetin betaPDL I DEC / 13
MethoxyfluranePDL I MAY / 18
Methyl salicylate in liquid dosage forms in concentrations greater than 30% II SEP / 98
MethyldesorphineN I JUN / 02
MethyldihydromorphineN I JUN / 02
Methyldopa or its saltsPDL I DEC / 13
Methylene Blue for parenteral use II SEP / 98
Methylnaltrexone or its saltsPDL

Including but not limited to methylnaltrexone bromide.

I JUN / 15
MethylparafynolPDL I DEC / 13
MethylphenidateC1 I JUN / 02
MethylphenobarbitalC2 I JUN / 02
MethylphenylisonipecotonitrileN I JUN / 02
MethyltestosteroneC3 I JUN / 02
MethyprylonTS I SEP / 98
Methysergide or its salts or derivativesPDL I DEC / 13
MetoclopramidePDL I DEC / 13
Metolazone or its saltsPDL I DEC / 13
Metomidate or its saltsPDL I DEC / 13
Metopimazine or its saltsPDL I DEC / 13

149 résultats


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled